On March 3, 2026, the U.S. District Court for the District of Columbia (“Court”) issued a seismic ruling effectively vacating several components of Health Resources and Services Administration’s ...

The 340B program spent $43.9 billion in 2021, supporting nearly 50,000 hospitals with discounted outpatient drugs. Cancer drugs constitute 41% of 340B purchases, with outpatient departments and ...

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

SPRINGFIELD, Ill. (WCIA) — Faith and community leaders gathered in Springfield on Wednesday to call for increased oversight ...

Weaknesses in the oversight of the 340 drug-pricing program may allow some hospitals to get discounts they are ineligible for, a newly released report from the Government Accountability Office found.

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

There are no requirements that hospitals pass discounts on to any patients, let alone the underserved. | Opinion ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

The drug discount program is under scrutiny on a variety of fronts ...